SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 78 filers reported holding SOLID BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $18,000 | -63.3% | 38,900 | -50.9% | 0.00% | – |
Q2 2022 | $49,000 | -16.9% | 79,273 | +59.7% | 0.00% | – |
Q1 2022 | $59,000 | -90.4% | 49,632 | -85.9% | 0.00% | – |
Q4 2021 | $614,000 | +12.5% | 350,824 | +53.6% | 0.00% | – |
Q3 2021 | $546,000 | -33.8% | 228,419 | +1.4% | 0.00% | – |
Q2 2021 | $825,000 | -39.6% | 225,312 | -8.7% | 0.00% | – |
Q1 2021 | $1,365,000 | -46.6% | 246,836 | -26.9% | 0.00% | – |
Q4 2020 | $2,558,000 | +5229.2% | 337,468 | +1319.8% | 0.00% | – |
Q3 2020 | $48,000 | -83.0% | 23,769 | -75.4% | 0.00% | – |
Q2 2020 | $283,000 | -73.2% | 96,494 | -78.2% | 0.00% | – |
Q1 2020 | $1,057,000 | -63.7% | 442,503 | -32.4% | 0.00% | -100.0% |
Q4 2019 | $2,913,000 | -17.2% | 654,379 | +92.4% | 0.00% | 0.0% |
Q3 2019 | $3,518,000 | -50.5% | 340,183 | -72.5% | 0.00% | – |
Q2 2019 | $7,109,000 | +25.2% | 1,236,382 | +100.3% | 0.00% | -100.0% |
Q1 2019 | $5,678,000 | -16.4% | 617,202 | +143.7% | 0.00% | +50.0% |
Q4 2018 | $6,788,000 | – | 253,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,929,918 | $13,877,000 | 1.10% |
EcoR1 Capital, LLC | 9,202,702 | $16,105,000 | 0.51% |
RA Capital Management | 12,367,873 | $21,644,000 | 0.38% |
Perceptive Advisors | 26,825,104 | $46,944,000 | 0.36% |
Boxer Capital, LLC | 3,177,702 | $5,561,000 | 0.22% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,287,193 | $11,003,000 | 0.21% |
Artal Group S.A. | 3,000,000 | $5,250,000 | 0.14% |
Ikarian Capital, LLC | 521,155 | $911,000 | 0.14% |
CAXTON ASSOCIATES LP | 177,571 | $311,000 | 0.03% |
ALGERT GLOBAL LLC | 136,138 | $238,000 | 0.03% |